Medtronic plc — Director's Dealing 2019

Sep 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-09-25

Reporting Person: Lenehan James T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-25	Ordinary Shares	M	1813	$44.13	Acquired	55464	Direct
2019-09-25	Ordinary Shares	F	744	$107.62	Disposed	54720	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-25	Stock Option (Right to Buy)	$44.13	M	1813	Disposed	2020-05-03	Ordinary Shares (1813)	Direct

Footnotes

F1: This balance increased by 129 shares due to exempt transactions such as dividend reinvestment.

F2: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.